Back to search
Psychosis;Schizophrenic
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Psychosis;Schizophrenic trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Psychosis;Schizophrenic trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This is a study of the efficacy and safety of BXCL501 in children and adolescents with acute agitation and either bipolar disorder or schizophrenia.
In recent years, art therapies have been discussed for their positive effects on mental disorders. One such therapy, clay therapy, is being studied to examine i…
The goal of this clinical pilot study is to learn how adults with schizophrenia or other non-affective psychotic disorders or psychosis risk syndromes experienc…
Disorders of social cognition, and empathy more specifically, are at the heart of schizophrenic pathology in that they are strongly linked to the social handica…
Schizophrenia affects about 0.7% of the population. Poor insight, which is common in this disease, linked to poor drug compliance is leads to rehospitalisation…
The main purpose of this study is to learn how transcranial magnetic stimulation (TMS) helps improve negative symptoms of schizophrenia. These 'negative symptom…
It is well established in studies across several countries that tobacco smoking is more prevalent among schizophrenic patients than the general population. Elec…